These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9313988)

  • 21. [External quality control in cervical cytopathology: an evaluation from 2000-2004].
    Rev Saude Publica; 2007 Dec; 41(6):1071. PubMed ID: 18066478
    [No Abstract]   [Full Text] [Related]  

  • 22. [How to read a PAP report?].
    Nieminen P
    Duodecim; 1998; 114(11):1138-43. PubMed ID: 11544696
    [No Abstract]   [Full Text] [Related]  

  • 23. Improving the benchmark. Makers of a better, more costly Pap test face a tough sell.
    Hensley S
    Mod Healthc; 1997 May; 27(19):52. PubMed ID: 10173014
    [No Abstract]   [Full Text] [Related]  

  • 24. Cervical cytology screening and evaluation.
    Noller KL
    Obstet Gynecol; 2005 Aug; 106(2):391-7. PubMed ID: 16055593
    [No Abstract]   [Full Text] [Related]  

  • 25. [A reply on cervix cancer screening: cervical cytological test doesn't fulfil the requirements of a good screening test].
    Bistoletti P
    Lakartidningen; 2000 Sep; 97(37):4042. PubMed ID: 11036367
    [No Abstract]   [Full Text] [Related]  

  • 26. Interobserver reproducibility: a new approach to quality control by using digital images (D.I. Test).
    Cariaggi MP; Confortini M; Mirri F; Tinacci G
    Acta Cytol; 2001; 45(3):488-90. PubMed ID: 11393094
    [No Abstract]   [Full Text] [Related]  

  • 27. Cytopathology in Austria.
    Breitenecker G; Dinges HP; Regitnig P; Wiener H; Vutuc Ch
    Cytopathology; 2004 Apr; 15(2):113-8. PubMed ID: 15056173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [On the occasion of the 65th birthday of the cervical smear: added value of population studies for cervical cancer remains unclear].
    Giard RW
    Ned Tijdschr Geneeskd; 2007 Jun; 151(23):1268-71. PubMed ID: 17624154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cervical cancer audit: and what is quality?
    Wilson PO
    Cytopathology; 2002 Jun; 13(3):141-4. PubMed ID: 12060075
    [No Abstract]   [Full Text] [Related]  

  • 30. Response to "access to cervical cancer screening: training internists so skill limitations are not a barrier to care".
    Savard M
    J Womens Health (Larchmt); 2007 Apr; 16(3):429. PubMed ID: 17439388
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cervical smears taken by physicians' assistants are of lesser quality than smears taken by family physicians, but almost as good as the national average].
    Voordijk-van der Ben MH; Buntinx F
    Ned Tijdschr Geneeskd; 2000 Jan; 144(2):74-7. PubMed ID: 10674106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality control in cytodiagnosis of carcinoma of the cervix.
    Chosia M; Marsan C; Ferrand J; Domagała W
    Pol J Pathol; 2000; 51(2):87-91. PubMed ID: 10974932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A perspective on modern quality control methods.
    Hutchinson ML; Lapidus SN; Inhorn SL; Papillo J
    Acta Cytol; 1996; 40(4):837-41. PubMed ID: 8693909
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluation of 100% rapid rescreening of negative cervical smears as a quality assurance measure.
    Manrique EJ; Amaral RG; Souza NL; Tavares SB; Albuquerque ZB; Zeferino LC
    Cytopathology; 2006 Jun; 17(3):116-20. PubMed ID: 16719853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Screening of cervical cancer, false negative smears].
    Vassilakos P; de Marval F; Muñoz M
    Rev Med Suisse Romande; 1998 Jan; 118(1):97. PubMed ID: 9580199
    [No Abstract]   [Full Text] [Related]  

  • 36. Cytopathology in Finland.
    Toivonen T; Nieminen P; Tarkkanen J; Timonen T; Krogerus L; Klemi P
    Cytopathology; 2005 Aug; 16(4):210-4. PubMed ID: 16048508
    [No Abstract]   [Full Text] [Related]  

  • 37. Papanicolaou Society of Cytopathology guidelines for educational notes, disclaimers, and similar comments on reports of cervical cytology specimens.
    Papanicolau Society of Cytopathology Practice Guidelines Task Force
    Diagn Cytopathol; 2003 May; 28(5):282-5. PubMed ID: 12722126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Re: using a quality control approach to define an 'adequately cellular' liquid-based cervical cytology specimen.
    Evered A
    Cytopathology; 2007 Oct; 18(5):325-6; author reply 326. PubMed ID: 17883693
    [No Abstract]   [Full Text] [Related]  

  • 39. Mistakes in cytopathology.
    Shane JJ
    Diagn Cytopathol; 1997 Dec; 17(6):488-90. PubMed ID: 9407216
    [No Abstract]   [Full Text] [Related]  

  • 40. One hundred percent thorough quality control rescreening of liquid-based monolayers in cervicovaginal cytopathology.
    Rowe LR; Marshall CJ; Bentz JS
    Cancer; 2002 Dec; 96(6):325-9. PubMed ID: 12478679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.